| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |